Medical Journals

Regulation of Glutamate Release from Primary Afferents and Interneurons in the Spinal Cord by Muscarinic Receptor Subtypes.

Authors:
  • Zhang Hong-Mei
  • Chen Shao-Rui
  • Pan Hui-Lin

From: Department of Anesthesiology and Pain Medicine, The University of Texas M.D. Anderson Cancer Center, 1400 Holcombe Blvd., Unit 409, Houston, TX 77030, USA.

Journal of neurophysiology

  • Publish Date: Jan 2007
  • ISSN: 0022-3077
  • Volume: 97
  • Issue: 1
  • Pages: 102-9
  • Medium: Print
  • Language: English
  • Citation (JAMA): Zhang Hong-Mei, Chen Shao-Rui, Pan Hui-Lin, et al. Regulation of Glutamate Release from Primary Afferents and Interneurons in the Spinal Cord by Muscarinic Receptor Subtypes.. J. Neurophysiol. Jan 2007;97:102-9

Abstract

Activation of spinal muscarinic acetylcholine receptors (mAChRs) produces analgesia and inhibits dorsal horn neurons through potentiation of GABAergic/glycinergic tone and inhibition of glutamatergic input. To investigate the mAChR subtypes involved in the inhibitory effect of mAChR agonists on glutamate release, evoked excitatory postsynaptic currents (eEPSCs) were recorded in lamina II neurons using whole cell recordings in rat spinal cord slices. The nonselective mAChR agonist oxotremorine-M concentration-dependently inhibited the monosynaptic and polysynaptic EPSCs elicited by dorsal root stimulation. Interestingly, oxotromorine-M caused a greater inhibition of polysynaptic EPSCs (64.7%) than that of monosynaptic EPSCs (27.9%). In rats pretreated with intrathecal pertussis toxin, oxotremorine-M failed to decrease monosynaptic EPSCs but still partially inhibited the polysynaptic EPSCs in some neurons. This remaining effect was blocked by a relatively selective M(3) antagonist 4-DAMP. Himbacine, an M(2)/M(4) antagonist, or AFDX-116, a selective M(2) antagonist, completely blocked the inhibitory effect of oxotremorine-M on monosynaptic EPSCs. However, the specific M(4) antagonist MT-3 did not alter the effect of oxotremorine-M on monosynaptic EPSCs. Himbacine also partially attenuated the effect of oxotremorine-M on polysynaptic EPSCs in some cells and this effect was abolished by 4-DAMP. Furthermore, oxotremorine-M significantly decreased spontaneous EPSCs in seven of 22 (31.8%) neurons, an effect that was blocked by 4-DAMP. This study provides new information that the M(2) mAChRs play a critical role in the control of glutamatergic input from primary afferents to dorsal horn neurons. The M(3) and M(2)/M(4) subtypes on a subpopulation of interneurons are important for regulation of glutamate release from interneurons in the spinal dorsal horn.

Mesh Headings (Keywords): Afferent Pathways, Animals, Drug Interactions, Excitatory Postsynaptic Potentials, Glutamic Acid, Interneurons, Male, Muscarinic Agonists, Muscarinic Antagonists, Neural Inhibition, Organ Culture Techniques, Posterior Horn Cells, Presynaptic Terminals, Rats, Rats, Sprague-Dawley, Receptor, Muscarinic M2, Receptor, Muscarinic M3, Receptor, Muscarinic M4, Receptors, Muscarinic, Spinal Cord, Spinal Nerve Roots, Synaptic Transmission


Check for Full Text / PubMed Unique Identifier (PMID): 17050831


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.